ELPA announces ELPA Pre-Summit on NAFLD
"Save the date! ELPA announces ELPA Pre-Summit on NAFLD – information for and from patients, patient experiences and views on NAFLD, as a back to back event to EASL NAFLD Summit on…
Ultrasound modules 3 and 4 now available on EASL Campus
Modules 3 and 4 of the EASL/EFSUMB Ultrasound of the Liver course are now available on EASL Campus. Module 3 – Focal liver lesions; the liver and biliary system Course description: The…
New online course on EASL Campus – HCC: Management of the side effects of immune checkpoint inhibitors
The HCC: Management of the side effects of immune checkpoint inhibitors course* is now available on EASL Campus. Course description : In this fascinating discussion, four of the leading experts in the field…
Survey: Lancet-EASL Commission on the care of liver cancer patients in Europe
The Lancet-EASL Commission is tackling liver diseases in Europe and overcoming unmet needs, stigma and inequities. The Commission is quantifying the burden of liver disease in Europe and addressing optimal diagnosis and…
LITMUS – Progress towards diagnosing and better treating liver disease
A pioneering European research project, designed to develop new diagnostic tests to assess patients with Non-Alcoholic Fatty Liver Disease (NAFLD) has expanded giving access to more patients. Incorporating several new partners also…
EASL opens call for new Scientific Committee member
EASL, the European Association for the Study of the Liver, is now calling for nominations for a new Scientific Committee member to join the Governing Board for a 3 year term starting…
Call for school proposals from EASL members
Call for schools 2021 EASL would like to provide its members with the ability to participate by opening a call for programme outline proposals and proposed topics. In 2021, EASL plans to…